NASDAQ:KTRA
Delisted

Kintara Therapeutics Stock Predictions

etoro logo Buy KTRA
*Your capital is at risk
$0.215
+0 (+0%)
At Close: Jan 16, 2025
Currently predicting for Fri, 5 Jun 2026

KTRA Prediction Chart

KTRA Predictions History

Latest community submissions for KTRA.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Feb 1, 2024 $0.152 +4.97% $0.129 X 82.17% 0
AlexVel AlexVel Pro
Feb 1, 2024 $0.142 -1.93% $0.129 V 89.92% 1
Feb 1, 2024 $0.135 -6.86% $0.129 V 95.46% 1
Feb 1, 2024 $0.139 -4.29% $0.129 V 92.57% 1
JS JS Pro
Jan 31, 2024 $0.123 -0.32% $0.145 X 84.94% 0
Jan 31, 2024 $0.133 +7.63% $0.145 V 91.72% 1
Jan 31, 2024 $0.129 +4.77% $0.145 V 89.28% 1
JS JS Pro
Jan 30, 2024 $0.128 +0.00% $0.123 V 96.27% 1
Jan 30, 2024 $0.116 -9.76% $0.123 V 93.60% 1
Jan 30, 2024 $0.136 +6.10% $0.123 X 89.94% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KTRA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KINTARA THERAPEUTICS INC.
Kintara Therapeutics
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intri...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE